Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Xerostomia 1Salivary Gland Neoplasms 1Radiation Injuries 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Cisplatin 4Carboplatin 4Biopsy 4trastuzumab deruxtecan 3Trastuzumab 3Platinum 3Goserelin 3Docetaxel 3sacituzumab govitecan 2pertuzumab 2entrectinib 2darolutamide 2Radiotherapy, Intensity-Modulated 2Leuprolide 2Ado-Trastuzumab Emtansine 21,2-diaminocyclohexaneplatinum II citrate 2zanidatamab 1trastuzumab biosimilar HLX02 1spartalizumab 1selinexor 1pyrotinib 1luprolide acetate gel depot 1lenvatinib 1larotrectinib 1enfortumab vedotin 1dehydroftorafur 1ceralasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Oral Hygiene × 1 year × Clear all
NCT02589938 2026-02-27

ACUPUNCTURE

Wake Forest University Health Sciences

Phase NA Completed
258 enrolled 16 charts
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡